RecruitingPhase 3NCT07602582
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Sponsor: Eli Lilly and Company
Aventura, FL · Bradenton, FL · Greenacres City, FL · +49 more sites
1 recruiting alzheimer's disease studies with a site in Greenacres City, FL.
All trials in Greenacres City, FL · All Alzheimer's Disease trials
Sponsor: Eli Lilly and Company
Aventura, FL · Bradenton, FL · Greenacres City, FL · +49 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.